Published May 27, 2008
RNdaze
11 Posts
i could only find 10 posts about lyme here, none under psych. i think we are missing a lot of patients with this, all over the country. i also think many don't seek help until their cognitive sx or depression overwhelm them. then, with the "psychiatric pt" label, they are forever held at arm's length, stripped or their credibility, and spiral downward.
what do you think? see?
overview of neuropsychiatric lyme disease
lyme disease may affect the brain in many ways, the most common of which is a disturbance in thinking (cognition).
other symptoms that occur frequently include headache, mood swings, irritability, depression, and marked fatigue.
this section will describe some of the typical and less typical features of neuropsychiatric lyme disease in adults.
lyme disease is transmitted by an ixodes tick infected with borrelia burgdorferi.
the spirochete which causes lyme disease (borrelia burgdorferi) can invade the central nervous system within days to a week of initial skin infection, as a result of dissemination through the blood stream.
the majority of patients who are treated early with antibiotics do well and incur no long term problems. patients who are not treated until later in the illness may have a more complicated course.
while the symptoms often seen among patients with neuropsychiatric lyme disease are not specific to lyme disease and can also be found in other disorders, knowing the typical clusters of symptoms can be helpful when considering lyme disease as a possible diagnosis.
the more multi-systemic the symptom presentation and the more clinical features observed in a patient from the list below, the more strongly lyme disease should be considered.
other diagnostic possibilities need to be considered in the differential diagnosis, such as mood or anxiety disorders, collagen vascular or autoimmune diseases, spinal cord compression, multiple sclerosis, metastatic diseases, endocrinological disorders, fibromyalgia, chronic fatigue syndrome, and residual damage from past brain trauma or toxin exposure.
a few points should be emphasized regarding late neuropsychiatric lyme disease.
first, although arthritis is helpful in the diagnosis of lyme disease, the majority of patients with cognitive troubles due to lyme disease (lyme encephalopathy) do not have joint problems at the time their cognitive symptoms become manifest. this is not widely recognized among physicians, although it is well documented in the medical literature.
second, the bedside neurologic exam does not usually disclose neurologic findings and standard office-based cognitive screening tests may not detect cognitive impairment. to detect thinking problems, the more sensitive tool of comprehensive neuropsychological testing conducted by a neuropsychologist is needed.
third, lumbar puncture while important in the differential diagnosis should not be used to exclude neurologic lyme disease, as roughly 20-40% of patients with confirmed neurologic lyme disease may test negative on routine csf assays.
among patients who develop chronic cognitive problems, the typical time course for the manifestation of lyme symptoms is as follows:
typical symptoms among patients with neuropsychiatric lyme disease:
cognitive aspects in adults:
psychiatric aspects in adults
irritability and moodiness are common. these tend to be most severe in neurologic lyme disease before treatment, during the first few days or weeks of treatment, and during resurgences or relapses of active lyme disease. antibiotic therapy can be very helpful at these times. symptoms that persist despite appropriate antibiotic therapy should be treated with psychiatric medications. it is very important for patients to take advantage of all opportunities for therapeutic benefit. these include consultation with a psychiatrist for both medication and therapy. psychotherapy with a psychiatrist, psychologist, or social worker can be very helpful to help the individual cope with the effects of a serious illness. family and couples therapy can also be vitally important, particularly when family members are confused by the changed behavior or personality of the patient. psychiatric medication can be very helpful to combat mood and sleep disturbances, to enhance attention, to decrease central nervous system hyperacuities, to decrease excessive worry and fear, and to contribute to overall good health by countering the negative impact of neuropsychiatric disorders on the immune system.
neuropsychiatric problems in children
as noted among adults, when lyme disease is treated early in children, few children develop long term problems. when lyme disease is not treated until later in the course of the illness, the clinical manifestations may be more neuropsychiatric and the response to treatment less robust.
in a large series of children with lyme disease referred to a pediatric neurologist (belman et al), headaches were the most commonly reported symptom.
the second most common symptom were disturbances of behavior and mood.
mri abnormalities may be seen in some children following lyme infection, located predominantly in the deep white matter, which is consistent with reports of mri lesions seen in adults with neuroborreliosis. these findings are similar to the mri findings of children with parainfectious or postinfectious acute disseminated encephalomyelitis.children in particular may appear to have "pseudo-tumor cerebri" because of an elevated opening pressure at lumbar puncture.
complex partial seizures may also occur more commonly among children with neurologic lyme disease than among adults.like adults, these children may appear to have chronic fatigue syndrome due to an extraordinary capacity for prolonged sleep at night and need for naps during the day.
cognitive. in a study by adams et al, children with relatively early manifestations of lyme disease appropriately treated with antibiotics were found to have an excellent prognosis for short-term and long-term (4 years) unimpaired cognitive functioning. in contrast, a study by bloom et al reported on an evaluation of 86 children for possible late manifestations of lyme disease, 12 of whom had neurocognitive symptoms thought to be related to lyme infection. of these 12, 5 had past or present b. burgdorferi infection in serum and csf and had developed neurocognitive symptoms either at the time of onset of lyme infection or months after classic manifestations of the disease. the most prevalent neurocognitive symptoms were behavioral changes, forgetfulness, declining school performance, headache and fatigue. two of these children had developed complex partial seizures. a comprehensive neuropsychological battery revealed that these children had normal intellectual functioning, but particular deficits related to auditory or visual sequential processing. these deficits, as well as many other symptoms, gradually improved following ceftriaxone therapy, although two of the children continued to have auditory sequential processing deficits.
a controlled study by dr. tager at our lyme disease research program, reported at the 1999 viii international lyme disease conference in munich germany, revealed that chronic lyme disease in children may be accompanied by cognitive and psychiatric disturbances, resulting in significant impairment in psychosocial and academic functioning. the most prominent cognitive problems involved the domains of attention and learning specifically related to perceptual/organizational abilities, visual scanning, and sequential tracking.
psychiatric.two studies from different institutions found that children with lyme disease may develop late problems with visual and auditory attention. these children may be mistakenly diagnosed as having primary attention deficit disorder as opposed to attentional deficits secondary to a systemic infection. other findings in children include new onset phobias (e.g., fear of the dark, separation anxiety), depression, listlessness and irritability, oppositional behavior,obsessive-compulsive behaviors, and/or tourettes disorder.
http://www.columbia-lyme.org/flatp/lymeoverview.html
tsalagicara
83 Posts
Oh, my god. This article just described how I have been feeling for several YEARS now. I got diagnosed with fibromyalgia, and I know this is a very real and debilitating condition, but I also know that there is some underlying problem causing my fibro symptoms. Have had really bad flare ups lately, and I am a nursing student. It is a struggle to get up and go to school every day, but I do it. Normally I am there every day on time and make good grades, but today I missed because I'm in so much pain. Thank you RNdaze, for posting this eye-opening article!! I was born and raised in an area of the country (Alabama) where tick bites are very common. I lost count of how many times I would go out to play and come back with several ticks on my body. I'm going to check into this more. Thanks again!! Also, RNDaze -- any other info you have on Lyme Disease please send to me, if you can.
i got diagnosed with fibromyalgia, and i know this is a very real and debilitating condition, but i also know that there is some underlying problem causing my fibro symptoms.
tsala - i hope you do find the source of your fibro. that is a difficult task indeed.
just wanted to add that the info provided in my post is just to give nurses in psych food for thought. we can't dx, but we can be informed.
in that vein, i'd like to point to a recent unprecedented event .... ct attny general blumenthal's antitrust investigation of the infectious disease society of america's lyme guidelines. whew, wonder what it feels like to be caught with your hand in the cookie jar.
for immediate release
contact: melissa chefec, 203-968-6625 or nicole rodgers, 202-822-5200, ext. 249/226
[color=#015351]settlement announced in landmark investigation of lyme disease diagnosis and treatment guidelines
[color=#015351]patients' rights groups applaud connecticut attorney general blumenthal's settlement in anti-trust case against powerful medical society
hartford, ct, may 1, 2008 - patients' rights groups today hailed connecticut attorney general blumenthal's announcement of a settlement in a landmark antitrust investigation into the lyme treatment guidelines of the infectious diseases society of america (idsa).
"my office uncovered undisclosed financial interests held by several of the most powerful idsa panelists," said blumenthal. "the idsa's guideline panel improperly ignored, or minimized, consideration of alternative medical opinion and evidence regarding chronic lyme disease, potentially raising serious questions about whether the recommendations reflected all relevant science."
the groundbreaking settlement announced today forces a complete review of the idsa guidelines by a new panel free from conflicts of interest, specifically excluding previous panel members. this panel will consider a range of scientific evidence in a public forum broadcast live over the internet and will be overseen by a specialist in financial conflicts of interest in medicine.
"this settlement makes it clear that the idsa guideline development process was corrupted by a commercially driven panel that excluded evidence supporting longer term treatment of lyme disease," said attorney lorraine johnson, executive director of the california lyme disease association (calda). "this settlement allows suppressed scientific viewpoints and evidence to be heard, and it is promising news for patients."
this is the first-ever antitrust investigation against a medical society's guidelines development process.
"we congratulate attorney general blumenthal for exposing the idsa's conflicts of interest and helping reduce the suffering of lyme patients everywhere," said pat smith, president of the national lyme disease association (lda). diane blanchard, co-president of time for lyme adds, "the idsa guidelines are dangerous for patients who suffer longer-term lyme symptoms that do not fall within the idsa's narrow disease definition."
the idsa guidelines are treated as mandatory within the medical community. more than 50 physicians who use longer-term treatment approaches have been investigated or sanctioned by state medical boards. the guidelines can also result in financial problems for patients, since insurance companies refuse to reimburse for longer-term treatment and pharmacies may refuse to fill prescriptions.
the majority of individuals involved in the idsa guidelines development process held direct or indirect commercial interests related to lyme vaccines, patents, and/or test kits, and did not take the opinions or experiences of the competing lyme groups into account.
while the announcement of a settlement comes as a huge relief to suffering lyme patients, the case has much broader implications for a health care system that often contends with conflicts-of-interest in guideline processes - guidelines which are often used by insurance companies to limit diagnosis and treatment options.
"today's settlement marks an important victory for all patients who suffer lyme disease, but it is also a victory for anyone concerned about health care," said johnson. "commercially driven guidelines that limit patient treatment options are a major issue today in healthcare, and this decision marks an important step towards addressing it."